180 related articles for article (PubMed ID: 38093320)
1. A novel "prime and pull" strategy mediated by the combination of two dendritic cell-targeting designs induced protective lung tissue-resident memory T cells against H1N1 influenza virus challenge.
Wang Z; He Y; Wang W; Tian Y; Ge C; Jia F; Zhang T; Zhang G; Wang M; Gong J; Huang H; Wang J; Shi C; Yang W; Cao X; Zeng Y; Wang N; Qian A; Jiang Y; Yang G; Wang C
J Nanobiotechnology; 2023 Dec; 21(1):479. PubMed ID: 38093320
[TBL] [Abstract][Full Text] [Related]
2. Homologous Sequential Immunization Using Salmonella Oral Administration Followed by an Intranasal Boost with Ferritin-Based Nanoparticles Enhanced the Humoral Immune Response against H1N1 Influenza Virus.
Wang Z; Zhang T; Jia F; Ge C; He Y; Tian Y; Wang W; Yang G; Huang H; Wang J; Shi C; Yang W; Cao X; Zeng Y; Wang N; Qian A; Wang C; Jiang Y
Microbiol Spectr; 2023 Jun; 11(3):e0010223. PubMed ID: 37154735
[TBL] [Abstract][Full Text] [Related]
3. CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
Lee W; Kingstad-Bakke B; Kedl RM; Kawaoka Y; Suresh M
J Virol; 2021 Jul; 95(15):e0053021. PubMed ID: 33952647
[TBL] [Abstract][Full Text] [Related]
4. Intranasal Nanoparticle Vaccination Elicits a Persistent, Polyfunctional CD4 T Cell Response in the Murine Lung Specific for a Highly Conserved Influenza Virus Antigen That Is Sufficient To Mediate Protection from Influenza Virus Challenge.
Nelson SA; Dileepan T; Rasley A; Jenkins MK; Fischer NO; Sant AJ
J Virol; 2021 Jul; 95(16):e0084121. PubMed ID: 34076479
[TBL] [Abstract][Full Text] [Related]
5. Chicken dendritic cell-targeting nanobodies mediated improved protective effects against H9N2 influenza virus challenge in a homologous sequential immunization study.
Jia F; Sun C; Ge C; Wang Z; Zhang T; Zhang M; Wang W; Tian Y; He Y; Yang G; Yang W; Shi C; Wang J; Huang H; Jiang Y; Wang C
Vet Microbiol; 2023 Oct; 285():109875. PubMed ID: 37729705
[TBL] [Abstract][Full Text] [Related]
6. Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein.
Luo J; Zheng D; Zhang W; Fang F; Wang H; Sun Y; Ding Y; Xu C; Chen Q; Zhang H; Huang D; Sun B; Chen Z
Virol J; 2012 Nov; 9():286. PubMed ID: 23173785
[TBL] [Abstract][Full Text] [Related]
7. Intranasal immunization with recombinant HA and mast cell activator C48/80 elicits protective immunity against 2009 pandemic H1N1 influenza in mice.
Meng S; Liu Z; Xu L; Li L; Mei S; Bao L; Deng W; Li L; Lei R; Xie L; Qin C; Zhang L
PLoS One; 2011; 6(5):e19863. PubMed ID: 21625486
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary immunization with a recombinant influenza A virus vaccine induces lung-resident CD4
Flórido M; Muflihah H; Lin LCW; Xia Y; Sierro F; Palendira M; Feng CG; Bertolino P; Stambas J; Triccas JA; Britton WJ
Mucosal Immunol; 2018 Nov; 11(6):1743-1752. PubMed ID: 30115996
[TBL] [Abstract][Full Text] [Related]
9. Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines.
Dong W; Bhide Y; Sicca F; Meijerhof T; Guilfoyle K; Engelhardt OG; Boon L; de Haan CAM; Carnell G; Temperton N; de Vries-Idema J; Kelvin D; Huckriede A
Front Immunol; 2018; 9():2312. PubMed ID: 30356772
[TBL] [Abstract][Full Text] [Related]
10. Intranasal co-administration of 1,8-cineole with influenza vaccine provide cross-protection against influenza virus infection.
Li Y; Xu YL; Lai YN; Liao SH; Liu N; Xu PP
Phytomedicine; 2017 Oct; 34():127-135. PubMed ID: 28899494
[TBL] [Abstract][Full Text] [Related]
11. T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine.
Li J; Arévalo MT; Chen Y; Chen S; Zeng M
Int J Infect Dis; 2014 Oct; 27():37-43. PubMed ID: 25172265
[TBL] [Abstract][Full Text] [Related]
12. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
13. Antibody-targeted vaccination to lung dendritic cells generates tissue-resident memory CD8 T cells that are highly protective against influenza virus infection.
Wakim LM; Smith J; Caminschi I; Lahoud MH; Villadangos JA
Mucosal Immunol; 2015 Sep; 8(5):1060-71. PubMed ID: 25586557
[TBL] [Abstract][Full Text] [Related]
14. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA
Front Immunol; 2019; 10():756. PubMed ID: 31105689
[TBL] [Abstract][Full Text] [Related]
15. Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses.
Matyushenko V; Kotomina T; Kudryavtsev I; Mezhenskaya D; Prokopenko P; Matushkina A; Sivak K; Muzhikyan A; Rudenko L; Isakova-Sivak I
Antiviral Res; 2020 Oct; 182():104864. PubMed ID: 32585323
[TBL] [Abstract][Full Text] [Related]
16. Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections.
Bernasconi V; Bernocchi B; Ye L; Lê MQ; Omokanye A; Carpentier R; Schön K; Saelens X; Staeheli P; Betbeder D; Lycke N
Front Immunol; 2018; 9():2060. PubMed ID: 30271406
[TBL] [Abstract][Full Text] [Related]
17. Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization.
Bhide Y; Dong W; Gribonika I; Voshart D; Meijerhof T; de Vries-Idema J; Norley S; Guilfoyle K; Skeldon S; Engelhardt OG; Boon L; Christensen D; Lycke N; Huckriede A
Front Immunol; 2019; 10():646. PubMed ID: 30984200
[TBL] [Abstract][Full Text] [Related]
18. Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus.
Yang S; Niu S; Guo Z; Yuan Y; Xue K; Liu S; Jin H
Virol J; 2013 Sep; 10():291. PubMed ID: 24053449
[TBL] [Abstract][Full Text] [Related]
19. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
[TBL] [Abstract][Full Text] [Related]
20. Vaccine Efficacy Induced by 2009 Pandemic H1N1 Virus-Like Particles Differs from that Induced by Split Influenza Virus.
Lee GJ; Chu KB; Inn KS; Moon EK; Quan FS
Immunol Invest; 2020 Oct; 49(7):781-793. PubMed ID: 31774021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
